Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
Marcus KirwanReema MunshiHannah O'KeeffeConor JudgeMary CoyleEvelyn DeasyYvelynne P KellyPeter J LavinMaria DonnellyDeirdre M D'ArcyPublished in: Critical care (London, England) (2021)
PTA simulations suggest that acceptable trough vancomycin concentrations can be achieved early in treatment with a 2 g loading dose and maintenance dose of 750 mg 12 hourly for critically ill patients on CVVHDF.